FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147775685> ?p ?o ?g. }

• W2147775685 endingPage "738" @default.
• W2147775685 startingPage "733" @default.
• W2147775685 abstract "To retrospectively review the oncologic outcomes of docetaxel-based chemotherapy in Japanese men with metastatic castration-resistant prostate cancer (mCRPC).This study included 257 consecutive Japanese patients with mCRPC who were treated with docetaxel-based chemotherapy between April 2007 and March 2010. The prognostic significance of several clinicopathologic factors in these patients was analyzed.In these 257 patients, the median age and serum value of prostate-specific antigen (PSA) prior to docetaxel-based chemotherapy were 72 years and 43.0 ng/ml, respectively. Of these patients, 64 (24.9%) and 193 (75.1%) received docetaxel as a weekly (30 mg/m(2)) and 3-weekly (70-75 mg/m(2)) regimen, respectively, and estramustine (EM) was administered in combination with docetaxel in 137 (53.3%). PSA decline was observed in 205 patients (79.8%), including 143 (55.6%) achieving PSA decline ≥ 50%. The median progression-free survival and overall survival (OS) were 4.3 and 25.4 months, respectively. Of several factors examined, univariate analysis identified performance status (PS), PSA value, significant clinical pain, bone metastasis, prior treatment with EM, treatment cycle, and PSA response as significant predictors of OS, of which only PS, significant clinical pain, prior treatment with EM, treatment cycle, and PSA response appeared to be independently related to OS on multivariate analysis. Furthermore, there were significant differences in OS according to positive numbers of these 5 independent risk factors.Oncologic outcomes in Japanese mCRPC patients receiving docetaxel-based chemotherapy is generally favorable, and the risk stratification presented in this study may contribute to precisely predicting the prognosis of such patients." @default.
• W2147775685 created "2016-06-24" @default.
• W2147775685 creator A5018885675 @default.
• W2147775685 creator A5040776712 @default.
• W2147775685 creator A5041954417 @default.
• W2147775685 creator A5043041975 @default.
• W2147775685 creator A5076120482 @default.
• W2147775685 date "2013-08-01" @default.
• W2147775685 modified "2023-10-02" @default.
• W2147775685 title "Oncological outcome of docetaxel-based chemotherapy for Japanese men with metastatic castration-resistant prostate cancer" @default.
• W2147775685 cites W1605426266 @default.
• W2147775685 cites W1615147444 @default.
• W2147775685 cites W1886024937 @default.
• W2147775685 cites W1992266822 @default.
• W2147775685 cites W2004973733 @default.
• W2147775685 cites W2026102934 @default.
• W2147775685 cites W2040393519 @default.
• W2147775685 cites W2050028052 @default.
• W2147775685 cites W2080439368 @default.
• W2147775685 cites W2082245048 @default.
• W2147775685 cites W2087567089 @default.
• W2147775685 cites W2102996930 @default.
• W2147775685 cites W2117783793 @default.
• W2147775685 cites W2119433516 @default.
• W2147775685 cites W2120292596 @default.
• W2147775685 cites W2123970190 @default.
• W2147775685 cites W2125942853 @default.
• W2147775685 cites W2127049292 @default.
• W2147775685 cites W2132296724 @default.
• W2147775685 cites W2132999564 @default.
• W2147775685 cites W2139995572 @default.
• W2147775685 cites W2151930316 @default.
• W2147775685 cites W2152524140 @default.
• W2147775685 cites W2155839539 @default.
• W2147775685 cites W2167331614 @default.
• W2147775685 cites W2170946635 @default.
• W2147775685 cites W2917015058 @default.
• W2147775685 cites W99134297 @default.
• W2147775685 doi "https://doi.org/10.1016/j.urolonc.2011.06.006" @default.
• W2147775685 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21782481" @default.
• W2147775685 hasPublicationYear "2013" @default.
• W2147775685 type Work @default.
• W2147775685 sameAs 2147775685 @default.
• W2147775685 citedByCount "20" @default.
• W2147775685 countsByYear W21477756852012 @default.
• W2147775685 countsByYear W21477756852013 @default.
• W2147775685 countsByYear W21477756852014 @default.
• W2147775685 countsByYear W21477756852015 @default.
• W2147775685 countsByYear W21477756852016 @default.
• W2147775685 countsByYear W21477756852018 @default.
• W2147775685 countsByYear W21477756852019 @default.
• W2147775685 countsByYear W21477756852021 @default.
• W2147775685 countsByYear W21477756852022 @default.
• W2147775685 crossrefType "journal-article" @default.
• W2147775685 hasAuthorship W2147775685A5018885675 @default.
• W2147775685 hasAuthorship W2147775685A5040776712 @default.
• W2147775685 hasAuthorship W2147775685A5041954417 @default.
• W2147775685 hasAuthorship W2147775685A5043041975 @default.
• W2147775685 hasAuthorship W2147775685A5076120482 @default.
• W2147775685 hasConcept C121608353 @default.
• W2147775685 hasConcept C126322002 @default.
• W2147775685 hasConcept C126894567 @default.
• W2147775685 hasConcept C143998085 @default.
• W2147775685 hasConcept C144301174 @default.
• W2147775685 hasConcept C2776694085 @default.
• W2147775685 hasConcept C2779013556 @default.
• W2147775685 hasConcept C2780192828 @default.
• W2147775685 hasConcept C2780201970 @default.
• W2147775685 hasConcept C2781190966 @default.
• W2147775685 hasConcept C2781406297 @default.
• W2147775685 hasConcept C2781413609 @default.
• W2147775685 hasConcept C2994223898 @default.
• W2147775685 hasConcept C38180746 @default.
• W2147775685 hasConcept C71924100 @default.
• W2147775685 hasConceptScore W2147775685C121608353 @default.
• W2147775685 hasConceptScore W2147775685C126322002 @default.
• W2147775685 hasConceptScore W2147775685C126894567 @default.
• W2147775685 hasConceptScore W2147775685C143998085 @default.
• W2147775685 hasConceptScore W2147775685C144301174 @default.
• W2147775685 hasConceptScore W2147775685C2776694085 @default.
• W2147775685 hasConceptScore W2147775685C2779013556 @default.
• W2147775685 hasConceptScore W2147775685C2780192828 @default.
• W2147775685 hasConceptScore W2147775685C2780201970 @default.
• W2147775685 hasConceptScore W2147775685C2781190966 @default.
• W2147775685 hasConceptScore W2147775685C2781406297 @default.
• W2147775685 hasConceptScore W2147775685C2781413609 @default.
• W2147775685 hasConceptScore W2147775685C2994223898 @default.
• W2147775685 hasConceptScore W2147775685C38180746 @default.
• W2147775685 hasConceptScore W2147775685C71924100 @default.
• W2147775685 hasIssue "6" @default.
• W2147775685 hasLocation W21477756851 @default.
• W2147775685 hasLocation W21477756852 @default.
• W2147775685 hasOpenAccess W2147775685 @default.
• W2147775685 hasPrimaryLocation W21477756851 @default.
• W2147775685 hasRelatedWork W1966846135 @default.
• W2147775685 hasRelatedWork W1988406497 @default.
• W2147775685 hasRelatedWork W2010765098 @default.
• W2147775685 hasRelatedWork W2043985321 @default.

• next